Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy.
Kabbara
Nabil
N
Lacroix
Claire
C
Peffault de Latour
Regis
R
Socié
Gérard
G
Ghannoum
Mahmoud
M
Ribaud
Patricia
P
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000601:surgery; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002175:Candida / Q000145:classification / Q000302:isolation & purification*; D002177:Candidiasis / Q000209:etiology* / Q000382:microbiology / Q000517:prevention & control; D000077336:Caspofungin; D054714:Echinocandins / Q000008:administration & dosage / Q000627:therapeutic use*; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use; D016469:Fungemia / Q000209:etiology* / Q000382:microbiology / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D055666:Lipopeptides; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000601:surgery; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000601:surgery; D011292:Premedication; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D017211:Treatment Failure
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D015725:Fluconazole; D000077336:Caspofungin